Diseases, Conditions, Syndromes

Recombinant vaccine confers more protection against influenza

A high-dose recombinant influenza vaccine is more effective than standard-dose vaccine among adults aged 50 to 64 years, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.

Health

CDC advice on who should get the latest COVID-19 vaccine

The Centers for Disease Control and Prevention has recommended the 2023–2024 COVID-19 (mRNA) vaccine for everyone six months or older. The COVID-19 vaccine is strongly recommended for people who face the highest risk of ...

page 2 from 40